Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on NOVARTIS AG
01/31 NOVARTIS : drug Votubia® receives EU approval to treat refractory partial-onset ..
01/30 NOVARTIS : highlights progress towards access and environmental goals in 2016 Co..
01/30 NOVARTIS : Alcon launches new trifocal toric intraocular lens for patients with ..
01/30 Swiss vote on multinational tax perks in February referendum
01/27 NOVARTIS : Special Notice - Intent to Sole Source-ALCON Ophthalmic Implants and ..
01/26 NOVARTIS : Patent Issued for Systems and Methods for Ocular Surgery (USPTO 95453..
01/26 NOVARTIS : Patent Issued for Acoustic Streaming Glaucoma Drainage Device (USPTO ..
01/26 NOVARTIS AG : Blog Coverage Novartis Announced Buyback of Shares Worth $5 Billio..
01/26DJNOVARTIS : Weighs Alcon Spinoff -- WSJ
01/26 NOVARTIS : highlights progress towards access and environmental goals in 2016 Co..
01/26 NOVARTIS : Alcon launches new trifocal toric intraocular lens for patients with ..
01/25 AMGEN : Novartis says court battle will delay its Enbrel copy until 2018 at leas..
01/25 NOVARTIS : beats 4Q profit forecasts
01/25DJVECTURA : Says Bronchitis Inhaler Sales Trigger Milestone Payment
01/25DJNOVARTIS : May Spin Off Alcon Eye-Care Business -- Update
01/25 NOVARTIS CEO : "The bigger the target, the higher the premium"
01/25 VECTURA : Says Novartis' Sales Of Breezhaler Products Hit USD512 Million
01/25DJNOVARTIS : Announces Share Buyback as Dollar Hits Earnings
01/25 NOVARTIS : delivered solid 2016 performance, with Growth Products absorbing Glee..
01/19 NOVARTIS : Patent Issued for Solid Oral Formulations and Crystalline Forms of an..
01/19 NOVARTIS : Patent Issued for MELK Regulation for the Treatment of Breast Cancer ..
01/19 NOVARTIS : Patent Issued for Integrated OCT-Refractometer System for Ocular Biom..
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/18 Drugmakers in Davos shift focus to chronic diseases of poor
01/16 NOVARTIS : invests in next generation therapies to reduce cardiovascular risk in..
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/13 NOVARTIS : NICE approves kidney cancer drug for NHS use
01/12 NOVARTIS : "Combination Therapy Comprising an Inhibitor of Jak, Cdk, and Pim" in..
01/12 NOVARTIS : Patent Issued for Pharmaceutical Combination Comprising a Phosphatidy..
01/09 IONIS PHARMACEUTICALS : Novartis invests in next generation therapies to reduce ..
01/09 NOVARTIS AG : Blog Coverage Novartis Joins Hands with Ionis Pharma For Cardiovas..
01/09 MOMENTA PHARMACEUTICALS,INC. (NASDAQ : MNTA) Files An 8-K Results of Operations ..
01/07 Momenta Provides Year-End 2016 Corporate Update
01/06 NOVARTIS : Patent Issued for MEMS Check Valve (USPTO 9528633)
01/06DJNOVARTIS : Correction to Novartis to Pay Up to $1.6 Billion to Ionis
01/06 NOVARTIS : Dr. Malte Peters to Become New Chief Development Officer of MorphoSys..
01/06DJNOVARTIS : to Pay Up to $1.6 Billion to Ionis, Unit for Rights to Two Cardiovasc..
01/06 NOVARTIS : invests in next generation therapies to reduce cardiovascular risk in..
01/05 SUBCONTRACTORS SOUND OFF : 5 ways to improve job site tech adoption
01/05 NOVARTIS : Athens Offices Raided in Bribery Probe, Exec Threatens With Suicide a..
01/05 NOVARTIS : Athens Offices Raided in Bribery Probe, Exec Threatens With Suicide a..
01/04 NOVARTIS : Greece investigates Novartis for alleged bribery
01/04 NOVARTIS : Prosecutors Raid Novartis Offices in Athens Over Bribery Allegations
01/04 NOVARTIS : Prosecutors Raid Novartis Offices in Athens Over Bribery Allegations
01/04 NOVARTIS : Greece investigates Novartis for alleged bribery
01/03 DECEMBER EDITION EBOOK : In brief
01/02 NOVARTIS : December edition eBook A BUMPER
2016 NOVARTIS : Protagen AG Successfully Joined Forces with Novartis to Support Clini..
2016 NOVARTIS : out-licenses three COPD products in the US
2016 NOVARTIS : Sunovion Enters into License Agreement for Three Approved Treatment O..
2016 DECEMBER EDITION EBOOK : In brief
2016 JOHNSON & JOHNSON : A lesson in putting family first
2016 NOVARTIS : Federal Contracts Awarded by Federal Agencies in Louisiana (Dec. 25)
2016 NOVARTIS : $252,156 Federal Contract Awarded to Alcon Laboratories
2016 NOVARTIS : Executive Q&A with Rodger P. McEver
2016 NOVARTIS : Sun Pharma signs deal to acquire oncology drug from Novartis
2016 SUN PHARMACEUTICAL INDUSTRIES : Pharma buys skin cancer drug Odomzo for $175 mn ..
2016 NOVARTIS : Sun Pharma steps up specialty biz, acquires cancer drug in $175 mn de..
2016 SUN PHARMACEUTICAL INDUSTRIES : Pharma to buy novartis' cancer drug for $175 mil..
2016 NOVARTIS : Alcon`s parent buys Fort Worth startup with treatment for aging eye c..
2016 SUN PHARMACEUTICAL INDUSTRIES : Pharma gains 1%; to acquire oncology product Odo..
2016 SUN PHARMACEUTICAL INDUSTRIES : Pharma to acquire oncology product Odomzo by Nov..
2016 DECEMBER EDITION EBOOK : In brief
2016 NOVARTIS : Sunovion Licenses Three COPD Therapies from Novartis
2016 NOVARTIS : Patent Issued for Inhibitors for Treating Diseases Characterized by A..
2016 NOVARTIS : Patent Issued for OCT Probe with Pivoting Fiber (USPTO 9517014)
2016 VECTURA : Says Novartis Inks Deal For Three COPD Treatments In The US
2016 E-BOOK EDITION IS ONLINE : In brief
2016 NOVARTIS : buying Fort Worth eye-care startup Encore Vision
2016 NETWORKNEWSBREAKS – CONATUS (N : CNAT) Skyrockets on Exclusive Licensing D..
2016 NOVARTIS : Upsher-smith divests amlactin brand family
2016 NOVARTIS : announces exclusive option, collaboration and license agreement with ..
2016 CONATUS PHARMACEUTICALS : Announces Exclusive Worldwide Option, Collaboration an..
2016 CONATUS PHARMACEUTICALS INC. (NASDAQ : CNAT) Files An 8-K Entry into a Material ..
2016 ACTINIUM PHARMA : ceuticals Appoints Jeannine Larrieux, Ph.D. as Director of Ana..
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2017 48 428 M
EBIT 2017 11 232 M
Net income 2017 7 504 M
Debt 2017 15 034 M
Yield 2017 3,79%
P/E ratio 2017 22,58
P/E ratio 2018 19,96
EV / Sales 2017 4,34x
EV / Sales 2018 4,13x
Capitalization 195 096 M
More Financials
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 32
Average target price 80,1 $
Spread / Average Target 7,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Joseph Jimenez Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Kirsch Chief Financial Officer
Vasant Narasimhan Chief Medical Officer & Head-Drug Development
Srikant Madhav Datar Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG-0.94%195 096
JOHNSON & JOHNSON8.91%340 163
ROCHE HOLDING LTD.8.60%219 545
PFIZER INC.4.68%202 474
MERCK & CO., INC.7.32%173 465
SANOFI7.76%115 582
More Results